Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 2Terminated 2

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 1Carcinoma, Renal Cell 1Acrocephalosyndactylia 1

Interventions

Cyclophosphamide 241Radiotherapy 217Gemcitabine 187Cisplatin 185Carboplatin 182Docetaxel 166Bevacizumab 166Paclitaxel 144Capecitabine 142Rituximab 141pembrolizumab 140Nivolumab 126Oxaliplatin 124Dexamethasone 122Fluorouracil 113fludarabine 104Radiosurgery 101Doxorubicin 99fludarabine phosphate 97Irinotecan 96Etoposide 95Lenalidomide 93Cytarabine 92Magnetic Resonance Spectroscopy 90Radiation 89Filgrastim 89Leucovorin 88Bortezomib 86Cetuximab 80Pemetrexed 79

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × OTHER × brivanib × Clear all
NCT01253668 2021-04-13

Brivanib Metastatic Renal Cell Carcinoma

Abramson Cancer Center at Penn Medicine

Phase 2 Terminated
10 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT01367275 2020-09-03

Irinotecan Plus Brivanib in Metastatic Colorectal Cancer (CRC) Enriched for Elevated Levels of Plasma FGF

M.D. Anderson Cancer Center

Phase 2 Terminated
8 enrolled 5 charts
Gastrointestinal

Acrocephalosyndactylia, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡